SCHEMBL5583011

SCHEMBL5583011

NC(=O)c1ccc(-c2cccc(F)c2F)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 2/20 0.53
MKNK2 Q9HBH9 2/20 0.53
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
HDAC3 O15379 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
MAPT P10636 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
ALDH1A1 P00352 1/20 0.50
PIM1 P11309 1/20 0.48
PIM3 Q86V86 1/20 0.48
CHEK2 O96017 1/20 0.47
PTGS1 P23219 1/20 0.46
PARP10 Q53GL7 2/20 0.46
TTR P02766 1/20 0.44
PARP1 P09874 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL607022 0.85 MAPT (0.67) MKNK1MKNK2NPC1RAB9AMAPT
SCHEMBL30958374 0.85 MAPT (0.67) MKNK1MKNK2NPC1RAB9AMAPT
Hydrochloric Acid SCHEMBL30684981 0.84 MAPT (0.65) MKNK1MKNK2NPC1RAB9AMAPT
SCHEMBL505283 0.84 TTR (0.65) NPC1RAB9AHDAC3HDAC1HDAC2
SCHEMBL12607543 0.81 ERN1 (0.52) MKNK1MKNK2NPC1RAB9AMAPT
SCHEMBL17141847 0.81 MAPT (0.77) NPC1RAB9AHDAC3HDAC1HDAC2
SCHEMBL13263254 0.80 WDR5 (0.47) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL5943856 0.79 HDAC6 (0.59) NPC1RAB9AHDAC3HDAC1HDAC2
SCHEMBL28264223 0.78 MKNK1 (0.61) MKNK1MKNK2NPC1RAB9AMAPT
SCHEMBL9723083 0.78 HDAC3 (0.58) NPC1RAB9AHDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070173498-A1 Melanin concentrating hormone antagonist KATO KANEYOSHI 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173498-A1 Melanin concentrating hormone antagonist MC1R, MCHR1, MCHR2 MKNK1 1509/4885MKNK2 1686/4885NPC1 1085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.